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Abstract 
 
According to WHO has identified so much people with tuberculosis disorder, and includes a 
disease that causes death. Mycobacterium tuberculosis has been resistant to antituberculosis drugs 
were used, while the discovery of new synthetic antituberculosis are very slow. Traditionally, 
mimba cortex has been used to treat cough and bloody sputum. In previous research proved that 
the ethanol extract of mimba cortex can inhibit the in vitro growth of Mycobacterium tuberculosis. 
This study was conducted to determine the potential of mimba cortex as antituberculosis in vivo and 
toxicity test. Antituberculosis potency test in vivo in guinea pigs infected with Mycobacterium 
tuberculosis H37Rv directly into the bronchi using nebulizer. Then given mimba cortex extract 3 
times a day 100 mg/kgBW and 50 mg/kgBW. Isoniazid, Rifampicin and Ethambutol used as a 
comparison. Antituberculosis assessment examination conducted by Mycobacterium tuberculosis on 
bronchial fluid speciments were taken every two weeks and tested in culture with Lowenstein-
Jensen method. Acute toxicity test conducted on mice, the LD50 value calculation and observation 
of liver, kidney, and lung histopathology. The result of research showed that the ethanol extract of 
mimba cortex have antituberculosis activity in guinea pigs which has infected with Mycobacterium 
tuberculosis H37Rv, 3 times daily dosing of 100 mg/kgBW for 6 weeks, showed that bacterium 
from +3 to negative, and 3 times daily dosing of 50mg/kgBW showed that bacterium from +3 to +1. 
Acute toxicity test results showed LD50 11.85 ± 0.571. That is including mild toxic category. 
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INTRODUCTION 
 
Tuberculosis (TB) is the infectious disease 
caused by the Mycobacterium tuberculosis which 
infect both latently or progressively and 
transmitted by human through cough and 
respiration mechanism. Mycobacterium 
tuberculosis is the acid resistant bacteria which 
have the spesific characteristic such as slow-rate 
growing but easily to become resistant. The slow-
rate growing character for this bacteria is one of 
the factor causing the development of 
antituberculosis is more difficult than the other 
antibacteria (Ganiswara, 1995).  
Tuberculosis is the threat for Indonesia 
society. In 2004, there were increase in the new 
cases of tuberculosis as many as 250,000 cases, 
and 140,000 death each year. Most of the 
tuberculosis patient are the productive age group 
aged 15-55 years old. This disease is the third 
deathly disease after cardiovascular disease and 
accute respirational disease in all age (Depkes RI, 
2005). 
The increase of the tuberculosis patient 
number is caused by some factors one of them is 
the uncompliance in the drugs therapy by the 
patient. The other factors are the high price of the 
drugs, multiple drug resistance, lack of hospes 
immunity against micobacteria, reduction in 
bactericidal power of the drugs, and patient 
economy crisis (Depkes RI, 2005). 
The drugs commonly used in the 
tuberculosis therapy are isoniazid, pirazinamid, 
rifampisin, ethambutol, and streptomycin. Most of 
the tuberculosis patient could be cure by those 
drugs, but the resistance phenomenon makes 
another choice for drugs therapy is needed 
(Wattimena, et al., 1991). 
Traditionally, mimba herbs (Azadiracta 
indica Juss) is used as the cure for some diseases, 
such as pertussis and cough up blood (Dalimata, 
1999). Numerous studies have reported that mimba 
seeds can inhibit the growth of Salmonella 
thyposa, Streptococcusaureus (Ambarwati, 2007), 
Streptococcus mutant and Streptococcus faecalis 
(Almas, 1999).  
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Mimba oils can also inhibit the growth of E. 
coli and Kleibsiella pneumonia (Sai Ram, et al., 
2000) besides, the etanolic extract of mimbacortex 
can inhibit the growth of Mycobacterium 
tuberculosis (Fatimah, 2012). 
Based on its empirical use property and the 
previous studies, mimba herbs have the potency as 
a natural antituberculosis agent. In this study, we 
determined the antituberculosis activity of 
ethanolic extract of mimba cortex (EEM) by in 
vivo assay using Mycobacterium tuberculosis 
H37RV infected marmot, and its toxicity using 
mice. The result of this research showed that 
mimba cortex potential to be developed as the 
alternative drugs of tuberculosis treatment. 
 
MATERIALS AND METHODS 
 
Plants Extraction 
Mimba cortex was dried and powdered, 
thenphytochemistry screening and quality test of 
simplisia was done. Extraction by percolation then 
conducted using 80% ethanol.  
 
Antituberculosis Activity Assay 
Antituberculosis activity of ethanolic 
extraxt of mimba cortex was determined using 
infected marmot. Marmot was spread using 3 mL 
suspension of Mycobacterium tuberculosis H37RV 
(from CV. Varka Bayak Medan) directly on 
bronchus by using nebulizer every 24 hours during 
7 days respectively, continued with once every 2 
days during 7 days and once every 3 days during 7 
days.  The spread of 20 mL aquadest was taken 
from esophagus. Identification and cultivation of 
Mycobacterium tuberculosis was done on LJ 
medium. The positive tuberculosis marmot then 
devided in 5 groups. Group 1: EEM 100 mg/kg 
BW, three times a day. Group 2: EEM 50 mg/kg 
BW, three times a day. Group 3: isoniazid control. 
Group 4: etambutol control. Group 5: rifampisin 
control. After administrated with each treatment, 
specimen sampling was done each week for 4-5 
samplings. Specimens were placed in test tube 
then homogenized with phosphate buffer pH 7 and 
inoculated into two test tubes contain with LJ 
medium. Inoculums were incubated in 37
o
C for 6-
8 weeks and the growth were observed with 
criteria: 
( - ) : no growth 
(+1) : medium covered with slight colony, 1 – 
200 colonies 
(+2) : ½ of medium surface covered with 
yellow colony, 200 – 500 colonies 
(+3) : ¾ of medium surface covered with 
yellow colony, 500 – 2000 colonies 
(+4) : all of medium surface covered with 
yellow colony >2000 colonies (Japan 
Intternational Coorperation Agency, 
1987). 
 
Toxicity Assay 
EEM was suspended in CMC-Na solution 
within 50% concentration.Toxicology assay was 
performed on 30 male mices (2-3 months), 
weighed from 20-30 grams, and were acclimatized 
for 7 days. Mices were devided 5 each treatments 
(WHO, 1993). Control treatment: CMC-Na 
control; treatment 1: EEM dose I; treatment 2: 
EEM dose II; treatment 3: EEM dose III; treatment 
4: EEM dose IV and treatment 5: EEM dose V. 
Toxicity assay was conducted in 3 stage of 
dose determination: dose orientation test, 
preliminary test, and actual test. LD50 was 
determined using Thompson Weil method in 
multilevel dose consists of 5 doses variant. 
Physical observation of toxic symptom was 
conducted intensively during 24 hours to all 
groups of mices. Observation was continued 
within 14 days. The number of dead mice in each 
group was scored then the LD50 range was 
determined according to the following formula: 
 
 
 
Annotation: 
m = LD50 
D = smallest dose 
d = multiple dose log 
f = Weil factor 
 
Liver, kidney and lung was removed then 
immediately washed by aquadest and soaked in 
formaline buffer 10% to perform the histopatology 
assay. 
 
RESULTS AND DISCUSSIONS 
 
The Antituberculosis Activity of EEM 
Antituberculosis activity assay was 
performed to 5 groups as explained in method 
section. The result indicates that there is an 
inhibition of bacterium growth. The number of 
bacterium before treatment is +3 (based on Japan 
International Coorperation Agency criteria). There 
is reduction from +3 to TB negative in control 
group at the third week of spacimen sampling. The 
reduction of bacterium number from +3 to 
negative TB in group 1 occurs at the fourth week 
of specimen sampling. 
Group 2 shows the reduction of bacterium 
number from +3 to +1 at the fourth week of 
specimen sampling. 
LD50range = antilog (Log m ± 2 x δ log m) 
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EEM Toxicity Assay 
First stage of test performed as orientation 
test to determine the dose administrated to the next 
stage of test. Mice were administrated with two 
multiple dose escalation of EEM and then 
observed during 24 hours until there is a death of 
mice. The result of this first test shows 20% death 
of group 4 which administrated with EEM dose 80 
mg/20 g BW.  
According to this orientation test result, 
preliminary test can be continued using the 
smallest dose of the orientation test. The 
preliminary test was conducted using EEM dose 
50 mg/20 g BW, the dose approaching 20% death 
dose, because there was no death after 40 mg/20 g 
BW dose administration. Dose then increased to be 
100 mg/20 g BW then observed during 24 hours. 
The result shows 0% death of group 1 and group 2. 
Based on the result, the actual test can be 
continued using the dose caused 0% death, 100 
mg/20 g BW. 
The assay then continued with minimal dose 
100 mg/20 g BW. The dose multification were 
increased based on the calculation below: 
 
R = 1.4142  
R = antilog d 
 
d = 
                    
                               
 
  
The calculation for dose multification 
between the groups and group 4 is 4, thus: 
 
d =
    
 
 
d =
     
 
 = 0.15051 
 
R = antilog 0.15051 = 1.4142 
 
The treatment were done for 14 days. 
Based on the assay, some male mice were dead by 
the single dose treatment in several dose of 
treatment. The LD50 value were calculated with 
Thompson well equation and the LD50 value is 
11.85 mg/kg BW per oral. The equation is stated 
below: 
 
Log m = Log D + d (f + 1) 
D = 141.42   
d = 0.15051   
f = based on Weil table 
r = 1,3,3,2 is = 0.50000  
 
Log m = Log D + d (f + 1) 
Log m = Log 141.42 +  0.15051 (0.50000 + 1) 
Log m = 2.1505 + 0.15051 (1.50000) 
Log m = 2.1505 + 0.2252   
Log m = 2.3757 mg/20 g BB 
       m  = antilog 2.3757 =  237.54 mg/20 g BB 
 
LD50  =  0.237 g/20 g BB 
LD50  =   11.85 g/ kg BB 
 
Then the LD50 range value was calculated. 
The LD50 range value is (11.85 ± 0.571) mg/kg 
BW.  
 
LD50 range value= antilog (log m ± 2  x  δ log m) 
δf  = based on Weil table  
r = 1,3,3,2  = 1. 90394 
d = 0.150151 
m = LD50 value = 0.237 g/20 g BW 
 
δ log m  =  0.150151 x 1.90394     
δ log m  = 0.28587   
 
LD50 range value= antilog (log m ± 2 x  δ log m) 
   = 0.237 ± 2 x  0.28587 
   = (0.237 ± 0.57175)g/20 g BW 
   = (11.85 ± 0.57)g/ kg BW 
 
Based on the LD50 range values shows 
that EEM classified in slightly toxic. The toxicity 
criteria of EEM single dose was determined using 
Frank C. Lu, (1995) criteria according to the 
following table: 
 
 
 
Table 1. Toxicity criteria based on the LD50 range values 
Criteria LD50 range values 
Super  toxic   5 mg/kgBB 
Highly toxic 5–50 mg/kgBB 
Very toxic 50-500 mg/kgBB 
Moderately toxic 0.5 – 5 g/kgBB 
Slightly toxic   15 g/kgBB 
Non toxic > 15 g/kgBB 
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Histopatology Analysis 
Histopatology interpretation shows that 
there is damage in liver, kidney and lung on each 
treatment groups and control group. Liver and 
kidney histopatology analysis can be performed 
with random observation in some field of view. 
The damage level of liver is increased from 
group 1, group 2, group 3, group 4 to group 5 
respectively. It shows that the EEM dose 
excalation can increase toxicity on mice liver. 
Histopatology analysis shows the necrosis 
on kidney according to proximal tubule 
constriction around glomerular. Control group 
shows 5% damage and the percent damage 
increases regarding to the dose level. The damage 
level of kidney is increased from group 1, group 2, 
group 3, group 4 to group 5 respectively. Group 5 
shows 20% damage on kidney and gives the most 
severe damage compare with the other groups. It 
means that the excalation of EEM dose level can 
increase toxicity in mice kidney. 
The result shows that EEM administration 
to mices in 14 days of observation period causes 
the liver and kidney damage on mice 
(Musmusculus Linn). EEM gives the toxic activity 
in dose dependent manner. The necrosis of liver 
was predicted caused by the active compound of 
EEM. Mimba herbs contain several active 
compound such as azadirachtin, salanin, 
meliantriole, nimbin, nimbolidedangedunin 
(Biswas, et al, 2002). 
 
CONCLUSION 
 
EEM can treat tuberculosis marmot infected 
with Myobacterium tuberculosis H37RV at the 
certain dose and is classified in slightly toxic.  
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